Literature DB >> 7655735

Expression of p53 and flow cytometric DNA analysis of isolated neoplastic glands of the stomach: an application of the gland isolation method.

Y Kitayama1, H Sugimura, M Tanaka, S Nakamura, I Kino.   

Abstract

The expression of p53 was studied immunohistochemically in combination with the DNA ploidy pattern by gland isolation in 97 alcohol-fixed gastric lesions. A polyclonal antibody, CM-1, was applied to the paraffin-embedded sections in this study. Overexpression of the p53 protein was found in 73.2% of 41 well or moderately differentiated gastric carcinomas and 52.2% of 23 cases with poor differentiation (P < 0.05). Immunoreactivity of p53 was also detected in isolated cancerous glands. No p53 immunoreactivity was detected in benign gastric lesions including adenomas, hyperplastic polyps and regions of intestinal metaplasia. In addition, flow cytometric DNA analysis was performed on isolated glandular epithelium adjacent to the portions used for immunostaining. DNA aneuploidy (DA) was detected in 85.7% of the well or moderately differentiated carcinomas and 42.9% of those with poor differentiation (P < 0.05). There was a positive correlation between DA, p53 positivity and the presence of regional lymph node metastasis, but not with other clinicopathological variables. In spite of the limited applicability of this method to poorly differentiated gastric cancer, we found that immunostaining and flow cytometry in combination with the gland isolation method facilitates analysis of gastric carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7655735     DOI: 10.1007/bf00192109

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  29 in total

Review 1.  Clinical implications of the p53 tumor-suppressor gene.

Authors:  C C Harris; M Hollstein
Journal:  N Engl J Med       Date:  1993-10-28       Impact factor: 91.245

2.  Methods for the determination of epithelial cell kinetic parameters of human colonic epithelium isolated from surgical and biopsy specimens.

Authors:  H Cheng; M Bjerknes; J Amar
Journal:  Gastroenterology       Date:  1984-01       Impact factor: 22.682

3.  p53 expression and prognosis in gastric carcinoma.

Authors:  H M Martin; M I Filipe; R W Morris; D P Lane; F Silvestre
Journal:  Int J Cancer       Date:  1992-04-01       Impact factor: 7.396

4.  Morphometrical and cell kinetic studies of normal human colorectal mucosa. Comparison between the proximal and the distal large intestine.

Authors:  T Arai; I Kino
Journal:  Acta Pathol Jpn       Date:  1989-11

5.  p53 protein immunostaining in routinely processed paraffin-embedded sections.

Authors:  J M Bruner; J H Connelly; H Saya
Journal:  Mod Pathol       Date:  1993-03       Impact factor: 7.842

6.  p53 expression in precancerous gastric lesions: an immunohistochemical study of PAb 1801 monoclonal antibody on adenomatous and hyperplastic gastric polyps.

Authors:  G Y Lauwers; S J Wahl; J Melamed; R R Rojas-Corona
Journal:  Am J Gastroenterol       Date:  1993-11       Impact factor: 10.864

7.  p53 mutation in gastric cancer: a genetic model for carcinogenesis is common to gastric and colorectal cancer.

Authors:  S Uchino; M Noguchi; A Ochiai; T Saito; M Kobayashi; S Hirohashi
Journal:  Int J Cancer       Date:  1993-07-09       Impact factor: 7.396

8.  Cytophotometric and flow cytometric DNA content of isolated glands in gastric neoplasia.

Authors:  Y Kitayama; S Nakamura; H Sugimura; I Kino
Journal:  Gut       Date:  1995-04       Impact factor: 23.059

9.  Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes.

Authors:  Y Kakeji; D Korenaga; S Tsujitani; H Baba; H Anai; Y Maehara; K Sugimachi
Journal:  Br J Cancer       Date:  1993-03       Impact factor: 7.640

10.  Clinicopathological significance of nuclear accumulation of tumor suppressor gene p53 product in primary lung cancer.

Authors:  H Hiyoshi; Y Matsuno; H Kato; Y Shimosato; S Hirohashi
Journal:  Jpn J Cancer Res       Date:  1992-01
View more
  3 in total

Review 1.  Clinical aspect and molecular mechanism of DNA aneuploidy in gastric cancers.

Authors:  Eiji Oki; Yuichi Hisamatsu; Koji Ando; Hiroshi Saeki; Yoshihiro Kakeji; Yoshihiko Maehara
Journal:  J Gastroenterol       Date:  2012-03-09       Impact factor: 7.527

2.  Analysis of chromosome 17p13 (p53 locus) alterations in gastric carcinoma cells by dual-color fluorescence in situ hybridization.

Authors:  M Kobayashi; A Kawashima; M Mai; A Ooi
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

3.  Infrequent overexpression of p53 protein in Epstein-Barr virus-associated gastric carcinomas.

Authors:  H Ojima; T Fukuda; T Nakajima; Y Nagamachi
Journal:  Jpn J Cancer Res       Date:  1997-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.